Cost Of Certification Under IVDR Is Going To Be Huge As Manufacturers Battle Hurdles
Executive Summary
There has been no recent impact assessment as to how business will be affected by the text of the IVD Regulation that was finally adopted. Consultant Robyn Meurant explains how industry will be paying a high price, and why many IVD companies could go under.
You may also be interested in...
European Parliament To Vote On MDR Delay As Council Rectifies Critical Mistake
The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.
Guidance Clarifies EU Position On Alternatives To Notified Body On-Site Audits
Virtual notified body audits of medtech manufacturers are already taking place through necessity. Now there is guidance concerning if, when, where and how these audits should be carried out.
Drug/Device Combinations: New Position Paper Explains Notified Body Responsibilities
Medicinal products authorities will consider a medtech notified body opinion on the device element of a drug/device combination product. A new position paper explains how roles and responsibilities are shared between medtech and medicinal product experts.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: